FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Recarbrio (imipenem, cilastatin, and relebactam) - July 16, 2019
- AirDuo Digihaler (fluticasone propionate and salmeterol) - July 15, 2019
- Katerzia (amlodipine benzoate) - July 08, 2019
- Xembify (immune globulin subcutaneous, human - klhw) - July 03, 2019
- Xpovio (selinexor) - July 03, 2019
- Thiola EC (tiopronin) - June 28, 2019
- Zirabev (bevacizumab-bvzr) - June 27, 2019
- Vyleesi (bremelanotide) - June 21, 2019
- Kanjinti (trastuzumab-anns) - June 13, 2019
- Polivy (polatuzumab vedotin-piiq) - June 10, 2019
- Piqray (alpelisib) - May 24, 2019
- Zolgensma (onasemnogene abeparvovec-xioi) - May 24, 2019
- Slynd (drospirenone) - May 23, 2019
- Nayzilam (midazolam) - May 17, 2019
- Ruzurgi (amifampridine) - May 06, 2019
- Vyndamax (tafamidis) - May 03, 2019
- Vyndaqel (tafamidis meglumine) - May 03, 2019
- Qternmet XR (dapagliflozin, metformin hydrochloride and saxagliptin) - May 02, 2019
- Dengvaxia (dengue tetravalent vaccine, live) - May 01, 2019
- Duobrii (halobetasol propionate and tazarotene) - April 25, 2019
